| Literature DB >> 34830165 |
Jaromír Vašíček1,2, Andrej Baláži1, Mária Tirpáková2,3, Andrea Svoradová1,4, Ľubomír Ondruška1, Vladimír Parkányi1, Peter Chrenek1,2.
Abstract
Human adipose tissue-derived mesenchymal stem cells (AT-MSCs) have been studied several years for their immunomodulatory effect through the paracrine mechanism and cytokine secretion. In combination with endothelial progenitor cells (EPCs), MSCs have great therapeutical potential for the repair of endothelium and wound healing. However, little is known about the cytokine profile of rabbit AT-MSCs or even EPCs. The aim of this study was to analyze the secretomes of these rabbit stem/progenitor cells. A large-scale human cytokine array (up to 80 cytokines) was used to identify and compare cytokines secreted into conditioned media of human and rabbit AT-MSCs as well as HUVECs and rabbit EPCs. Few cytokines were highly expressed by human AT-MSCs (TIMP-2, TIMP-1), HUVECs (MCP-1, TIMP-2, GRO, Angiogenin, IL-8, TIMP-1), or by rabbit EPCs (TIMP-2). Several cytokines have moderate expression by human (MCP-1, GRO, Angiogenin, TGF-β 2, IL-8, LIF, IL-6, Osteopontin, Osteoprotegerin) and rabbit AT-MSCs (TIMP-2, TGF-β 2, LIF, Osteopontin, IL-8, IL-5, IL-3) or by HUVECs (IL-6, MIF, TGF-β 2, GCP-2, IGFBP-2, Osteoprotegerin, EGF, LIF, PDGF-BB, MCP-3, Osteopontin, Leptin, IL-5, ENA-78, TNF-β) and rabbit EPCs (TGF-β 2, Osteopontin, GRO, LIF, IL-8, IL-5, IL-3). In conclusion, the proposed method seems to be useful for the secretome analysis of rabbit stem/progenitor cells.Entities:
Keywords: EPCs; MSCs; adipose tissue; cytokine array; rabbit
Mesh:
Year: 2021 PMID: 34830165 PMCID: PMC8625496 DOI: 10.3390/ijms222212283
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Expression of cytokines by human and rabbit stem/progenitor cells. Representative images of fluorescent cytokine antibody array for analyses of 80 cytokines in human and rabbit samples (A). Heat map showed a normalized expression of all analyzed cytokines in different human and rabbit samples (B). AT-MSCs—adipose tissue-derived mesenchymal stem cells; HUVECs—human umbilical vein endothelial cells; EPCs—endothelial progenitor cells.
Overview of analyzed cytokines according to their normalized expression in different cell types.
| Cell Type/Mean Fluorescent | Human AT-MSCs | Rabbit AT-MSCs | HUVECs | Rabbit EPCs |
|---|---|---|---|---|
| 60,000–25,000 | TIMP-2, TIMP-1 | N.D. | MCP-1, TIMP-2, GRO, Angiogenin, IL-8, TIMP-1 | TIMP-2 |
| 25,000–2000 | MCP-1, GRO, Angiogenin, TGF-β 2, IL-8, LIF, IL-6, Osteopontin, Osteoprotegerin | TIMP-2, TGF-β 2, LIF, Osteopontin, IL-8, IL-5, IL-3 | IL-6, MIF, TGF-β 2, GCP-2, IGFBP-2, Osteoprotegerin, EGF, LIF, PDGF-BB, MCP-3, Osteopontin, Leptin, IL-5, ENA-78, TNF-β | TGF-β 2, Osteopontin, GRO, LIF, IL-8, IL-5, IL-3 |
| 2000–200 | IL-5, MCP-3, TNF-β, IL-3, SDF-1, Leptin, TGF-β 1, VEGF, IL-1a, IP-10, HGF, Oncostatin M, IL-7, IL-15, IGFBP-3, IL-13, TNF-α, Flt-3 Ligand, GCP-2, IL-12 p70, MIG, MCSF, IL-2, NT-4, MIF, SCF, PARC, GCSF, IFN-g, IGF-I, NT-3, GM-CSF, Eotaxin-3, MCP-2, IL-10, BDNF, MIP-1b, PlGF, EGF, Thrombopoietin, GRO-a, FGF-9, GDNF, FGF-6, MDC, ENA-78, FGF-4, PDGF-BB, MCP-4, MIP-3 a, IGFBP-1, IL-1 b, TARC, Ck b 8-1, IGFBP-2, LIGHT, RANTES, Eotaxin, FGF-7, BLC, Fractalkine, MIP-1d, I-309, Eotaxin-2, IGFBP-4 | TNF-β, Leptin, IL-1a, MCP-3, GRO, IP-10, Oncostatin M, TIMP-1, TGF-β 1, IL-12 p70, NT-4, SDF-1, IL-7, IL-15, MIP-3 a, MCP-1, VEGF, PARC, TNF-α, MCSF, NT-3, IFN-g, Angiogenin, MIF, Eotaxin-3, Flt-3 Ligand, IGF-I, SCF, MDC, GRO-a, IL-2, IL-13, IGFBP-3, MIG, GCSF, BDNF, GDNF, MIP-1b, FGF-9, GM-CSF, PlGF, IL-10, MCP-2, FGF-6, Thrombopoietin, FGF-4, IGFBP-1, IL-6, EGF, PDGF-BB, MCP-4, HGF, TARC, ENA-78, IL-1 b, BLC, IGFBP-2, Eotaxin, RANTES, GCP-2, MIP-1d, IGFBP-4, Fractalkine, Eotaxin-2, IL-4, I-309, FGF-7, Ck b 8-1, LIGHT, Osteoprotegerin, NAP-2, IL-16 | IL-3, IL-7, IP-10, MIG, IL-15, IL-1a, TNF-a, IL-12 p70, TGF-β 1, IL-13, HGF, Eotaxin-3, Oncostatin M, IL-2, VEGF, NT-4, PlGF, MCSF, SCF, IGFBP-3, GCSF, IFN-g, Flt-3 Ligand, GM-CSF, IL-10, MIP-1b, MCP-2, PARC, LIGHT, MDC, SDF-1, FGF-9, GRO-a, BLC, FGF-6, Fractalkine, GDNF, IGF-I, Thrombopoietin, Eotaxin, NT-3, FGF-4, MCP-4, Ck b 8-1, NAP-2, IL-1 b, TARC, MIP-1d, FGF-7, BDNF, Eotaxin-2, MIP-3 a, IGFBP-4, RANTES | TNF-β, MCP-3, Leptin, IL-1a, TIMP-1, SDF-1, IL-12 p70, TGF-β 1, Angiogenin, IP-10, Oncostatin M, PARC, EGF, IL-7, NT-4, IL-15, MCSF, Flt-3 Ligand, IGF-I, VEGF, TNF-α, IL-13, SCF, NT-3, IL-2, MIP-3 a, Eotaxin-3, MCP-1, IFN-g, MDC, GRO-a, GCSF, MIF, BDNF, PlGF, MIG, IGFBP-3, GM-CSF, MCP-2, Thrombopoietin, IL-10, MIP-1b, IL-6, FGF-6, FGF-9, GDNF, FGF-4, IGFBP-1, MCP-4, PDGF-BB, Ck b 8-1, HGF, TARC, IL-1 b, IGFBP-2, Eotaxin, BLC, IGFBP-4, Eotaxin-2, RANTES, GCP-2, LIGHT, Osteoprotegerin, FGF-7, MIP-1d, IL-4, ENA-78, Fractalkine, I-309, NAP-2 |
| <200 (negative) | IL-16, IL-4, NAP-2, TGF-β 3 | TGF-β 3 | IGFBP-1, IL-4, I-309, IL-16, TGF-β 3 | IL-16, TGF-β 3 |
Cytokines in the table cells are arranged according to their descending expression (mean fluorescent intensity); N.D.—not detected within the range specific for the table line.
Figure 2The mostly secreted cytokines compared according to the same cell type and different animal species. Ten cytokines with the highest expression in each cell type were chosen for the comparison. hAT-MSCs—human adipose tissue-derived mesenchymal stem cells; rAT-MSCs—rabbit adipose tissue-derived mesenchymal stem cells; HUVECs—human umbilical vein endothelial cells; rEPCs—rabbit endothelial progenitor cells. The data from three independent experiments are expressed as the means ± SD; ***—difference is statistically significant at p < 0.001.
Figure 3The mostly secreted cytokines compared according to the same animal species and different cell type. Ten cytokines with the highest expression in each cell type were chosen for the comparison. hAT-MSCs—human adipose tissue-derived mesenchymal stem cells; HUVECs—human umbilical vein endothelial cells; rAT-MSCs—rabbit adipose tissue-derived mesenchymal stem cells; rEPCs—rabbit endothelial progenitor cells. The data from three independent experiments are expressed as the means ± SD; **—difference is statistically significant at p < 0.01; ***—difference is statistically significant at p < 0.001.
The mostly expressed cytokines by different cell types classified according to their biological function.
| Cell Type/ | Human AT-MSCs | Rabbit AT-MSCs | HUVECs | Rabbit EPCs |
|---|---|---|---|---|
| Pro-angiogenic | MCP-1, GRO, Angiogenin, TGF-β 2, IL-8, IL-6, Osteopontin | TGF-β 2, Osteopontin, IL-8, IL-5, IL-3, TNF-β, Leptin, IL-1a | MCP-1, GRO, Angiogenin, IL-8, IL-6, MIF, TGF-β 2, GCP-2 | TGF-β 2, Osteopontin, GRO, IL-8, IL-5, IL-3, TNF-β, MCP-3 |
| Anti-angiogenic | TIMP-2, TIMP-1 | TIMP-2 | TIMP-2, TIMP-1 | TIMP-2 |
| Pro-inflammatory | TIMP-1, MCP-1, GRO, Angiogenin, TGF-β 2 (according to circumstances), IL-8, LIF (according to circumstances), IL-6, Osteopontin | TGF-β 2 and LIF (according to circumstances), Osteopontin, IL-8, IL-3, TNF-β, Leptin, IL-1a | MCP-1, GRO, Angiogenin, IL-8, TIMP-1, IL-6, MIF, TGF-β 2 (according to circumstances), GCP-2 | TGF-β 2 (according to circumstances), Osteopontin, GRO, LIF (according to circumstances), IL-8, IL-3, TNF-β, MCP-3 |
| Anti-inflammatory | TIMP-2, TGF-β 2 and LIF (according to circumstances) | TIMP-2, TGF-β 2 and LIF (according to circumstances), IL-5 | TIMP-2, TGF-β 2 (according to circumstances) | TIMP-2, TGF-β 2 and LIF (according to circumstances), IL-5 |
| Neuroregulatory | LIF | LIF | LIF | LIF |
| Adipokines | TIMP-2, TIMP-1, MCP-1, GRO, Angiogenin, TGF-β 2, IL-8, LIF, IL-6, Osteopontin | TIMP-2, TGF-β 2, LIF, Osteopontin, IL-8, IL-5, Leptin, IL-1a | MCP-1, TIMP-2, GRO, Angiogenin, IL-8, TIMP-1, IL-6, MIF, TGF-β 2, GCP-2 | TIMP-2, TGF-β 2, Osteopontin, GRO, LIF, IL-8, IL-5, MCP-3 |
Complete list of analyzed cytokines in alphabetical order.
| Human Cytokine Array G5 | ||||
|---|---|---|---|---|
| Angiogenin | BDNF | BLC | CK b 8-1 | EGF |
| ENA-78 | Eotaxin | Eotaxin-2 | Eotaxin-3 | FGF-4 |
| FGF-6 | FGF-7 | FGF-9 | Flt-3 Ligand | Fractalkine |
| GCP-2 | GCSF | GDNF | GM-CSF | GRO-a |
| GRO | HGF | I-309 | IFN-g | IGF-I |
| IGFBP-1 | IGFBP-2 | IGFBP-3 | IGFBP-4 | IL-1a |
| IL-1 b | IL-2 | IL-3 | IL-4 | IL-5 |
| IL-6 | IL-7 | IL-8 | IL-10 | IL-12 p40/p70 |
| IL-13 | IL-15 | IL-16 | IP-10 | Leptin |
| LIF | LIGHT | MCP-1 | MCP-2 | MCP-3 |
| MCP-4 | MCSF | MDC | MIF | MIG |
| MIP-1b | MIP-1d | MIP-3 a | NAP-2 | NT-3 |
| NT-4 | Oncostatin M | Osteopontin | Osteoprotegerin | PARC |
| PDGF-BB | PlGF | RANTES | SCF | SDF-1 alpha |
| TARC | TGF-β 1 | TGF-β 2 | TGF-β 3 | Thrombopoietin |
| TIMP-1 | TIMP-2 | TNF-α | TNF-β | VEGF |
BDNF—Brain-derived neurotrophic factor; BLC—B lymphocyte chemoattractant; CK b 8-1 (CCL23)—C-C motif chemokine 23; EGF—Pro-epidermal growth factor; ENA-78—Epithelial-derived neutrophil-activating protein 78; FGF-4—Fibroblast growth factor 4; FGF-6—Fibroblast growth factor 6; FGF-7—Fibroblast growth factor 7; FGF-9—Fibroblast growth factor 9; Flt-3 Ligand—Fms-related tyrosine kinase 3 ligand; GCP-2—Granulocyte chemotactic protein 2; GCSF—Granulocyte colony-stimulating factor; GDNF—Glial cell line-derived neurotrophic factor; GM-CSF—Granulocyte–macrophage colony-stimulating factor; GRO-a—Growth-regulated alpha protein; GRO—Reacts with CXCL1, CXCL2, and CXCL3 (GRO alpha, beta, and gamma, respectively); HGF—Hepatocyte growth factor; I-309 (CCL1)—C-C motif chemokine 1; IFN-g—Interferon gamma; IGF-I—Insulin-like growth factor I; IGFBP-1—Insulin-like growth factor-binding protein 1; IGFBP-2—Insulin-like growth factor-binding protein 2; IGFBP-3—Insulin-like growth factor-binding protein 3; IGFBP-4—Insulin-like growth factor-binding protein 4; IL-1a—Interleukin-1 alpha; IL-1 b—Interleukin-1 beta; IL-2—Interleukin-2; IL-3—Interleukin-3; IL-4—Interleukin-4; IL-5—Interleukin-5; IL-6—Interleukin-6; IL-7—Interleukin-7; IL-8—Interleukin-8; IL-10—Interleukin-10; IL-12—Interleukin-12; IL-13—Interleukin-13; IL-15—Interleukin-15; IL-16—Interleukin-16; IP-10—Interferon gamma-induced protein; LIF—Leukemia inhibitory factor; LIGHT (TNFSF14)—Tumor necrosis factor ligand superfamily member 14; MCP-1—Monocyte chemoattractant protein 1; MCP-2—Monocyte chemoattractant protein 2; MCP-3—Monocyte chemoattractant protein 3; MCP-4—Monocyte chemoattractant protein 4; MCSF—Macrophage colony-stimulating factor 1; MDC—Macrophage-derived chemokine; MIF—Macrophage migration inhibitory factor; MIG—Monokine induced by interferon-gamma; MIP-1b—Macrophage inflammatory protein 1-beta; MIP-1d—Macrophage inflammatory protein 1-delta; MIP-3 a—Macrophage inflammatory protein 3 alpha; NAP-2—Neutrophil-activating peptide 2; NT-3—Neurotrophin-3; NT-4—Neurotrophin-4; PARC—Pulmonary and activation-regulated chemokine; PDGF-BB—Platelet-derived growth factor subunit B; PlGF—Placenta growth factor; RANTES (CCL5)—C-C motif chemokine 5; SCF—Stem cell factor; SDF-1—Stromal cell-derived factor 1; TARC(CCL17); TGF-β 1—Transforming growth factor beta-1; TGF-β 2—Transforming growth factor beta-2; TGF-β 3—Transforming growth factor beta-3; TIMP-1—Metalloproteinase inhibitor 1; TIMP-2—Metalloproteinase inhibitor 2; TNF-α —Tumor necrosis factor alpha; TNF-β —Tumor necrosis factor beta; VEGF—Vascular endothelial growth factor. The explanation of the cytokine abbreviations was obtained from the UniProt Database (http://www.uniprot.org/; accessed 10 October 2021).